Details of the Drug Reposition

General Information of This Drug (ID: DMDNJP5)

Drug Name
NM21-1480   DMDNJP5
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Advanced solid tumour DISBICMY 2A00-2F9Z Phase 1/2 [1]
Non-small-cell lung cancer DISI0V1B 2C25 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04442126) A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors. U.S. National Institutes of Health.